Literature DB >> 21932060

Lentivirus-mediated ADAM17 RNA interference inhibited interleukin-8 expression via EGFR signaling in lung epithelial cells.

Yaqing Li1, Jianping Yan, Wulin Xu, Hong Wang, Yingjie Xia.   

Abstract

Interleukin (IL)-8 and neutrophil inflammation play a vital role in the pathogenesis of chronic inflammatory airway diseases. A disintegrin and metalloproteinase 17 (ADAM17) cleaves ectodomains of various transmembrane proteins and is an important regulator of almost every cellular event. The aim of this work was to investigate the roles of epidermal growth factor receptor (EGFR) signaling and ADAM17 in IL-8 expression induced by lipopolysaccharide (LPS) in A549 lung epithelial cells. In the present study, we found that transforming growth factor-α (TGF-α)-neutralizing Ab, EGFR-neutralizing Ab, and AG1478 significantly inhibited the phosphorylation of EGFR and IL-8 production induced by LPS. Lentivirus-mediated ADAM-17 RNA interference markedly inhibited ADAM-17 expression, the release of TGF-α, and the phosphorylation of EGFR and IL-8 expression. The results demonstrated that lentivirus-mediated RNA interference targeting ADAM17 suppressed IL-8 expression induced by LPS via inhibiting EGFR signaling, and ADAM17-EGFR signaling cascade mediated IL-8 production induced by LPS in lung epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21932060     DOI: 10.1007/s10753-011-9386-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

Review 1.  Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications.

Authors:  Hui-Wen Lo
Journal:  Discov Med       Date:  2010-07       Impact factor: 2.970

2.  Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD.

Authors:  Victor M Pinto-Plata; Guy Livnat; Mirle Girish; Howard Cabral; Phil Masdin; Paul Linacre; Rick Dew; Lawrence Kenney; Bartolome R Celli
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

Review 3.  [Chemokines (IL-8, MCAF/MCP-1, RANTES, MIP-1 etc.)].

Authors:  Shoji Yokochi; Kouji Matsushima
Journal:  Nihon Rinsho       Date:  2005-04

4.  The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma.

Authors:  L M Hamilton; C Torres-Lozano; S M Puddicombe; A Richter; I Kimber; R J Dearman; B Vrugt; R Aalbers; S T Holgate; R Djukanović; S J Wilson; D E Davies
Journal:  Clin Exp Allergy       Date:  2003-02       Impact factor: 5.018

Review 5.  ADAMs in cancer cell proliferation and progression.

Authors:  Satsuki Mochizuki; Yasunori Okada
Journal:  Cancer Sci       Date:  2007-03-09       Impact factor: 6.716

6.  Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study.

Authors:  Dave Singh; Lisa Edwards; Ruth Tal-Singer; Stephen Rennard
Journal:  Respir Res       Date:  2010-06-15

7.  Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells.

Authors:  Matt X G Shao; Jay A Nadel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

Review 8.  Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases.

Authors:  P-R Burgel; J A Nadel
Journal:  Eur Respir J       Date:  2008-10       Impact factor: 16.671

9.  Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells.

Authors:  Martine Charbonneau; Kelly Harper; Francine Grondin; Manuela Pelmus; Patrick P McDonald; Claire M Dubois
Journal:  J Biol Chem       Date:  2007-09-19       Impact factor: 5.157

10.  Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin.

Authors:  B Rada; P Gardina; T G Myers; T L Leto
Journal:  Mucosal Immunol       Date:  2010-10-20       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.